Dr. Pamela Palmer Discusses Prevention of Risk in Patient Controlled Analgesia Pump [Podcast]

Published Online: Tuesday, August 30, 2011

In this interview, Pamela P. Palmer, MD, PhD, an anesthesiologist and pain specialist co-founder of AcelRx, has witnessed first hand the risk and harm caused by patient-controlled analgesia pumps and talks about how the new product created by AcelRX will put a stop to all theses incidents. The AcelRx is preprogrammed PCA system, which eliminates the risk of pump programming errors. The use of sufentanil NanoTabs, (an extremely small tablet which dissolves under the patients’ tongue) which eliminates the risk of IV-related analgesic gaps and the risk of IV complications.

Comment(s)

Your comments are valuable to us. Thank you.

Sorry, you must be logged in and registered to post a comment.

Safer Pain Patch with 7x Potency Enters Phase II

Key Concerns for Pain Management in Elderly Patients

More Teens Are Abusing Prescription Drugs

Insights into Inflammation and Wound Healing, Research Roundup

Home Wrecker (part one)

Correlates of Perceived Pain-related Restrictions Among Women with Fibromyalgia

The Placebo Effect in Pain Management

Guarding Patient Privacy in the Age of Facebook and Twitter

Home Wrecker (part 2) - Revenge of the Primary Care Provider

Can Hospitalist Co-management Services Improve Patient Outcomes?

American Journal of Managed Care
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
Pharmacy Times
Physician's Money Digest

About Us
Contact Us
Advertise
Terms & Conditions
Newsroom
iPad & iPhone
Social Network
Blogs